Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20438511 | 0.94 | LMNA (0.41) | LMNAALDH1A1KDM4CKDM4APHF8 | |
| SCHEMBL517872 | 0.90 | LMNA (0.50) | LMNAALDH1A1KDM4CKDM4APHF8 | |
| SCHEMBL10225592 | 0.89 | LMNA (0.38) | LMNAALDH1A1CYP1A2MAPK1PLA2G1B | |
| SCHEMBL22753506 | 0.89 | LMNA (0.38) | LMNAALDH1A1CYP1A2MAPK1PLA2G1B | |
| SCHEMBL17277117 | 0.89 | PLA2G1B (0.40) | LMNAKDM4CPHF8MAPK1OPRM1 | |
| SCHEMBL8464998 | 0.88 | LMNA (0.48) | LMNAALDH1A1KDM4CKDM4APHF8 | |
| SCHEMBL1507508 | 0.88 | LMNA (0.48) | LMNAALDH1A1KDM4CKDM4APHF8 | |
| SCHEMBL20438365 | 0.88 | LMNA (0.41) | LMNAALDH1A1KDM4CKDM4APHF8 | |
| SCHEMBL1020474 | 0.88 | LMNA (0.48) | LMNAALDH1A1KDM4CKDM4APHF8 | |
| SCHEMBL1507494 | 0.88 | LMNA (0.48) | LMNAALDH1A1KDM4CKDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115991633-B | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2024-06-25 | — | — | CN | claimed |
| CN-115991633-A | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2023-04-21 | — | — | CN | claimed |
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-110590844-A | Preparation method for synthesizing tenofovir alafenamide by two-step method | 江西农业大学 | 2019-12-20 | — | — | CN | claimed |
| CN-110551153-A | Preparation method for synthesizing tenofovir alafenamide by three-step method | UNIV JIANGXI AGRICULTURAL | 2019-12-10 | — | — | CN | claimed |
| US-9226925-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2016-01-05 | — | — | US | claimed |
| US-8940729-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-01-27 | — | — | US | claimed |
| US-8912217-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-12-16 | — | — | US | claimed |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | DAICEL CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4012726-B1 | ADHESIVE CONDUCTIVE PASTE | DAICEL CORP (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-20250269473-A1 | CONDUCTIVE PASTE FOR BONDING | DAICEL CORPORATION (JP) | 2025-08-28 | — | — | US | disclosed |
| EP-4589607-A1 | BONDING CONDUCTOR PASTE | Daicel Corporation (JP) | 2025-07-23 | — | — | EP | disclosed |
| CN-115777128-B | Conductive ink | 株式会社大赛璐 | 2025-06-03 | — | — | CN | disclosed |
| EP-4549055-A1 | INK COMPOSITION | Daicel Corporation (JP) | 2025-05-07 | — | — | EP | disclosed |
| US-5739388-A | Process for the preparation of aromatic compounds by decarboxylation of aromatic carboxylic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | disclosed |
| EP-0811601-A1 | Process for the preparation of aromatic carbonic acid esters | Clariant GmbH (DE) | 1997-12-10 | — | — | EP | disclosed |
| EP-0757028-A1 | Process for the preparation of aromatic carbonic acid esters | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-02-05 | — | — | EP | disclosed |
| EP-0741122-A1 | Process for preparing aromatic compounds through decarboxylation of aromatic carboxylic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-11-06 | — | — | EP | disclosed |
| US-4615977-A | AMINE DERIVATIVES PROMOTE GROWTH WITH LOW SERUM CONCENTRATIONS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1986-10-07 | — | — | US | disclosed |
| EP-0082974-B1 | METHOD FOR THE CULTIVATION OF NORMAL DIPLOID CELLS AND CULTIVATION MEDIUM USED THEREFOR | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1986-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | MARK3, OR10J3, ILK | LMNA 2730/4885ALDH1A1 3032/4885KDM4C 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.